These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 12322767)
21. The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? Nickel JC BJU Int; 2004 Dec; 94(9):1230-3. PubMed ID: 15610095 [No Abstract] [Full Text] [Related]
23. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Wagenlehner FM; Naber KG Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930 [TBL] [Abstract][Full Text] [Related]
24. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. Rapp RP Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590 [TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and treatment of prostatitis: a case report]. Braham I; Charefeddine B; Neffatti S; Othmane LB; Smach M; Letaief A; Dridi H; Limem K Ann Biol Clin (Paris); 2009; 67(5):577-80. PubMed ID: 19789132 [TBL] [Abstract][Full Text] [Related]
26. [Comprehensive therapy for chronic bacterial prostatitis: report of 52 cases]. Zhou DQ; Wen HT; Tan WL Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):368-9. PubMed ID: 12390750 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. Nickel JC; Xiang J J Urol; 2008 Apr; 179(4):1391-5. PubMed ID: 18289570 [TBL] [Abstract][Full Text] [Related]
28. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. Jeong CW; Lim DJ; Son H; Lee SE; Jeong H Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485 [TBL] [Abstract][Full Text] [Related]
29. [Asymptomatic prostatitis: a frequent cause of raising PSA]. Terrone C; Poggio M; Bollito E; Cracco CM; Scarpa RM Recenti Prog Med; 2005; 96(7-8):365-9. PubMed ID: 16209120 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance. Martin M; Quilici S; File T; Garau J; Kureishi A; Kubin M J Antimicrob Chemother; 2007 May; 59(5):977-89. PubMed ID: 17395688 [TBL] [Abstract][Full Text] [Related]
31. The role of antibiotics in chronic bacterial prostatitis. Wagenlehner FM; Weidner W; Sörgel F; Naber KG Int J Antimicrob Agents; 2005 Jul; 26(1):1-7. PubMed ID: 15970433 [TBL] [Abstract][Full Text] [Related]
32. [Cost effectiveness of screening for prostate cancer]. Kaprin AD; Naĭgovzina NB; Ivanov SA; Bashmakov VA Vopr Onkol; 2006; 52(6):680-5. PubMed ID: 17338249 [TBL] [Abstract][Full Text] [Related]
34. [Large kidney due to levofloxacin]. Castellanos Monedero JJ; Rodríguez García JL; Arambarri Segura M; Carreño Parrilla A; Blanco J Nefrologia; 2008; 28(6):662-3. PubMed ID: 19016650 [No Abstract] [Full Text] [Related]
35. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis. Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631 [TBL] [Abstract][Full Text] [Related]
36. Chronic prostatitis in Korea: a nationwide postal survey of practicing urologists in 2004. Ku JH; Paick JS; Kim SW Asian J Androl; 2005 Dec; 7(4):427-32. PubMed ID: 16281092 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of long-term therapy with norfloxacin in chronic bacterial prostatitis. Peppas T; Petrikkos G; Deliganni V; Zoumboulis P; Koulentianos E; Giamarellou H J Chemother; 1989 Jul; 1(4 Suppl):867-8. PubMed ID: 16312677 [No Abstract] [Full Text] [Related]